Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jaguar Animal Health (JAGX) has issued an announcement.
Jaguar Health, Inc. stockholders approved all four proposals during a special meeting on April 9, 2024, including a reverse stock split to meet Nasdaq’s minimum bid price requirement and the issuance of common stock upon the exchange of Series J Preferred Stock. The company had previously received a delisting warning from Nasdaq due to its stock price falling below $1.00, and a subsequent delisting determination letter when the bid price dropped to $0.10. Jaguar Health has been granted an extension until August 13, 2024, to regain compliance with Nasdaq’s listing rules.
See more insights into JAGX stock on TipRanks’ Stock Analysis page.